Today: 19 June 2026
AMD stock price leaps 8% on KeyBanc call as Feb. 3 earnings near
22 January 2026
2 mins read

AMD stock price leaps 8% on KeyBanc call as Feb. 3 earnings near

NEW YORK, Jan 22, 2026, 04:52 (EST) — Premarket

  • AMD’s stock ended Wednesday up roughly 7.6%, closing at $249.80.
  • KeyBanc highlighted a tight supply of 2026 server chips and the possibility of price increases, drawing focus to company guidance.
  • AMD added a new member to its board, as a busy schedule of chip earnings keeps investors watching closely.

Shares of Advanced Micro Devices (AMD.O) jumped roughly 7.6% Wednesday, closing at $249.80. The sharp gain has put the stock back in focus heading into Thursday’s session.

Why it matters now: the rally comes just before AMD’s upcoming earnings and guidance release. Investors will be keenly watching for concrete data on demand in data centers and the company’s ability to maintain pricing power.

The focus isn’t only on server processors but also AI chips. Nvidia continues to dominate the high end of AI accelerators—the graphics processors powering large model training and deployment. AMD, meanwhile, faces pressure to prove it can deliver volume shipments on schedule.

On Jan. 21, KeyBanc stuck with its Overweight rating and $270 price target on AMD, citing robust demand for the company’s latest “Turin” server CPUs—the core processors powering data-center hardware. The broker noted hyperscalers, the largest cloud providers, are already locking in capacity for 2026. AMD is nearing a sellout of server CPU supply through the end of that year and is mulling price hikes between 10% and 15%. KeyBanc also forecasted AI GPU revenue hitting $14 billion to $15 billion in 2026, while emphasizing the rollout of AMD’s MI455 chips and the Helios rack-scale system. Investing.com

AMD revealed a shakeup on its board this week, bringing on KC McClure, the ex-CFO of Accenture, as a new director. CEO Lisa Su expressed she was “delighted to welcome KC,” highlighting McClure’s “operating expertise and global perspective.” AMD

A regulatory filing revealed AMD increased its board size from eight to nine directors, adding McClure to the audit and finance committee. According to the filing, she was granted 1,278 restricted stock units, a type of stock award that usually vests gradually.

AMD’s advance followed strong action in semiconductors. Nvidia climbed roughly 3%, Intel surged close to 12% on Wednesday, and semiconductor ETFs like SOXX and SMH added about 3%. The broader market benchmarks QQQ and SPY ended the day higher as well.

Still, with the stock already up, there’s little margin for missteps if product rollouts delay or guidance disappoints—especially in the high-end GPU space where AMD is pushing to wrest market share from Nvidia. KeyBanc analyst John Vinh told The Motley Fool that investors will be zeroing in on customer wins and production timelines during the next earnings call.

Intel will drop its earnings after the bell on Thursday, offering an early glimpse into chip demand ahead of AMD’s report. The results could push the sector sharply in either direction.

AMD plans to release its fiscal fourth-quarter and full-year 2025 earnings on Feb. 3, after markets close. The company will hold a conference call at 5:00 p.m. EST. Additionally, CTO Mark Papermaster is scheduled to speak at Morgan Stanley’s Technology, Media & Telecom Conference on March 3.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Pfizer Shares Drop as CFO Departure Sparks 2026 Outlook Concerns
    June 19, 2026, 9:57 AM EDT. Pfizer shares dipped 2.7% to $25.21 following CFO Dave Denton's announcement to leave on Aug. 15, raising questions about the company's 2026 outlook. Cecile Guegan will step in as interim CFO from Aug. 16 while Pfizer conducts a search for a permanent replacement. Denton's exit, unrelated to financial or operational disagreements, comes as Pfizer navigates reduced COVID vaccine demand and aims to bolster growth through new drugs and cost cuts. Despite CEO Albert Bourla expressing confidence in Guegan, investor concerns persist amid leadership changes and uncertain pipeline developments. Pfizer reaffirmed its 2026 sales target of $59.5 billion to $62 billion, but market reaction reflects cautious sentiment ahead.

Latest articles

Air Canada Stock Sticks Close to 52-Week High; Middle East Tensions Resurface

Air Canada Stock Sticks Close to 52-Week High; Middle East Tensions Resurface

19 June 2026
Air Canada surged 4.6% to C$24.20, just one cent below its 52-week high, as lower oil prices fueled a rally despite the company’s withdrawn 2026 outlook due to volatile fuel costs; with U.S. airline peers idle for Juneteenth and analyst price targets lagging, investors face heightened risk if Middle East tensions push jet fuel higher.
BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”
Previous Story

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX
Next Story

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Go toTop